Eletriptan Hydrobromide Tablet, Film Coated
Product Images NDC 70771-1108

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Eletriptan Hydrobromide (NDC 70771-1108). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Eletriptan Hydrobromide Tablet (8cbfff26 Bdf1 425c A96c E32c82c0934f 04)

Eletriptan Hydrobromide Tablets 20 mg film-coated tablet label featuring the active ingredient strength, quantity of 30 tablets, and oral route. The label includes manufacturer information from Cadila Healthcare Ltd., Ahmedabad, India, and branding from Zydus Pharmaceuticals. The label also lists storage instructions and usage notes, with NDC 70771-1107-3 visible.*

FDA Label Image

Eletriptan Hydrobromide Tablet (8cbfff26 Bdf1 425c A96c E32c82c0934f 05)

Eletriptan Hydrobromide Tablets 40 mg film-coated oral tablets packaging label from Zydus Lifesciences Limited. The label notes a 30-tablet count, with storage instructions and a warning to keep out of children's reach. Manufactured by Cadila Healthcare Ltd., Ahmedabad, India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.